John Ridley - Concepedia

Author

John Ridley

University of Bristol

Also Known As

J RIDLEY, J. M. Ridley, J.M. Ridley, John M Ridley, John M. Ridley, John Ridley

Publications

531

Citations

H-Index

Concepts

All Affiliations

University of Bristol Pfizer (United Kingdom)

About

John Ridley is an author at University of Bristol specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	358
2	Biochemistry	3	3	173
3	Cell Biology	2	2	95
4	Natural Sciences	1	1	55
5	Allergy	1	1	49

John Ridley

Publications

518

Citations

H-Index

Page 1

	Year	Citations
High affinity HERG K+ channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656 John Ridley, James T. Milnes, Harry J. Witchel, Biochemical and Biophysical Research Communications Molecular PharmacologyS6 Residues Y652BiochemistryAntiarrhythmic Agent DronedaroneMedicine	2004	76
Preferential closed channel blockade of HERG potassium currents by chemically synthesised BeKm‐1 scorpion toxin James T. Milnes, Christopher E. Dempsey, John Ridley, FEBS Letters	2003	72
Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin Rona S. Duncan, Mark J. McPate, John Ridley, Biochemical Pharmacology	2007	57
Lidoflazine is a high affinity blocker of the HERG K+channel John Ridley Journal of Molecular and Cellular Cardiology Molecular PharmacologyBiochemistryMedicineNatural SciencesMechanism Of Action	2004	55
Inhibition of HERG K<sup>+</sup> Current and Prolongation of the Guinea‐Pig Ventricular Action Potential by 4‐Aminopyridine John Ridley, James T. Milnes, Y. H. Zhang, The Journal of Physiology Cardiac MuscleExperimental PharmacologyCellular PhysiologyMolecular PharmacologyHyperpolarization (Biology)	2003	53
Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel John Ridley, James T. Milnes, Jules C. Hancox, Journal of Molecular and Cellular Cardiology AllergyHerg K+ ChannelMedicineAntiparasitic AgentPharmacology	2005	49
Erythromycin block of the HERG K+ channel: Accessibility to F656 and Y652 Rona S. Duncan, John Ridley, Christopher E. Dempsey, Biochemical and Biophysical Research Communications Molecular PharmacologySignal TransductionBiochemistryHerg K+ ChannelMedicine	2006	42
Inhibition of the HERG K<sup>+</sup>channel by the antifungal drug ketoconazole depends on channel gating and involves the S6 residue F656 John Ridley, James T. Milnes, Rona S. Duncan, FEBS Letters	2006	31
Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide John Ridley, James T. Milnes, Andrew V. Benest, Biochemical and Biophysical Research Communications Molecular PharmacologyHyperpolarization (Biology)MedicinePhysiologyClinical Pharmacology	2003	31
Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene—without QT interval prolongation Kathryn H. Yuill, John J. Borg, John Ridley, Biochemical and Biophysical Research Communications Molecular PharmacologyMedicinePhysiologyCardiovascular PharmacologyIon Channels	2004	29

Page 1